SCHEMBL19860029

SCHEMBL19860029

Cc1c(F)cc(F)cc1-c1c[nH]c2ncc(-n3cc(N4CCN(S(C)(=O)=O)CC4)cn3)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIK1 P57059 1/20 0.35
SIK3 Q9Y2K2 1/20 0.35
JAK2 O60674 3/20 0.35
PIK3CD O00329 2/20 0.35
ROCK2 O75116 2/20 0.35
SRC P12931 2/20 0.35
PRKACA P17612 2/20 0.35
KDR P35968 2/20 0.35
FLT3 P36888 2/20 0.35
PIK3CG P48736 2/20 0.35
GSK3A P49840 2/20 0.35
GSK3B P49841 2/20 0.35
ROCK1 Q13464 2/20 0.35
PIK3CA P42336 1/20 0.34
TDO2 P48775 2/20 0.34
CLK1 P49759 2/20 0.33
DYRK1A Q13627 2/20 0.33
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33
MAPK1 P28482 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15805271 0.89 SIK1 (0.47) SIK1SIK3JAK2PIK3CDROCK2
SCHEMBL19860030 0.84 MAP4K1 (0.44) SIK1SIK3CLK1DYRK1AMAPK1
SCHEMBL17636825 0.78 SIK1 (0.50) SIK1SIK3JAK2PIK3CDROCK2
SCHEMBL15805269 0.76 MAPK1 (0.40) JAK2TDO2MAPK1MAP4K1
SCHEMBL19860023 0.75 SIK1 (0.60) SIK1SIK3PIK3CDPIK3CAALK
SCHEMBL15805267 0.73 MAP4K1 (0.48) SIK1SIK3CLK1DYRK1ACDK9
SCHEMBL19860025 0.71 SIK1 (0.46) SIK1SIK3ALKMAP4K1
SCHEMBL19860026 0.67 SIK1 (0.59) SIK1SIK3PIK3CDPIK3CAALK
SCHEMBL15799340 0.65 SIK1 (0.77) SIK1SIK3CCNT1CDK9ALK
SCHEMBL30830390 0.65 SIK1 (0.77) SIK1SIK3CCNT1CDK9ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890153-B2 Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2018-02-13 US disclosed